Document is current
Any future updates will be listed below
-
Authors
Messiou, Christina https://orcid.org/0000-0002-0557-9379
Porta, Nuria
Koh, Dow-Mu
Riddell, Angela
Downey, Katherine
Croft, James
Conneely, Leonora
Hopkinson, Georgina https://orcid.org/0000-0003-4967-8886
Dragan, Alina
Brown, Tommy
Stern, Simon
Cheung, Betty
Kyriakou, Charalampia
Kaczmarek, Pawel
Boyd, Kevin
Pawlyn, Charlotte https://orcid.org/0000-0002-7190-0028
Winfield, Jessica
Kaiser, Martin F. https://orcid.org/0000-0002-3677-4804
-
Funding
Funding for this research was provided by:
NIHR Biomedical Research Center at The Royal Marsden and Insitute of Cancer Research CRUK National Cancer Imaging Translational Accelerator
- License Information
-
More Information
Article History
Received: 7 March 2025
Revised: 17 June 2025
Accepted: 25 June 2025
First Online: 17 July 2025
Competing interests
: CM: received an honorarium from Sanofi for an educational event. MK: Honoraria: Janssen, Sanofi; Consultancy: Janssen, BMS, AbbVie, GSK, Pfizer, Regeneron, Poolbeg, Sanofi, Roche, Adaptive; Research Funding: Janssen, Celgene/BMS KB: Honoraria: Janssen/J+J, BMS, Sanofi; Consultancy: Janssen/J+J, BMS, Pfizer, Pharmaand; Support to Attend Educational Meetings: J+J, Pfizer. The authors declare no competing interests.
